{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Macropinocytosing human anti-CD46 antibodies and targeted cancer therapeutics", "item": "https://www.patentleaderboard.com/patent/10533056"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Macropinocytosing human anti-CD46 antibodies and targeted cancer therapeutics

Macropinocytosing human anti-CD46 antibodies and targeted cancer therapeutics

US Patent 10533056 · Granted Jan 14, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method and internet of things (IoT) system for managing gas data2025
Industrial internet of things with sensing network platform in post-sub-platform2025
Methods and internet of things systems for processing work orders of gas platfor2025
Method and internet of things system of charging information recommendation for 2025
Intelligent manufacturing methods and systems based on Industrial Internet of Th2025
Methods and smart gas internet of things systems for determining gas abnormity f2025
Methods and internet of things (IoT) systems for abnormality troubleshooting at 2025
Method for gas pipeline network supervision based on smart gas and internet of t2025
1H-imidazo[4,5-h]quinazoline compound as protein kinase inhibitor2025
Reconfigurable processor-based programmable switching fabric and programmable da2025
Leave-on oral care compositions2025
Rho-associated protein kinase inhibitor, pharmaceutical composition comprising s2025